PDSB
Price
$1.24
Change
-$0.02 (-1.59%)
Updated
Apr 30, 11:04 AM (EDT)
Capitalization
57.2M
14 days until earnings call
RXRX
Price
$5.39
Change
-$0.33 (-5.77%)
Updated
Apr 30, 11:17 AM (EDT)
Capitalization
2.3B
5 days until earnings call
Ad is loading...

PDSB vs RXRX

Header iconPDSB vs RXRX Comparison
Open Charts PDSB vs RXRXBanner chart's image
PDS Biotechnology
Price$1.24
Change-$0.02 (-1.59%)
Volume$480
Capitalization57.2M
Recursion Pharmaceuticals
Price$5.39
Change-$0.33 (-5.77%)
Volume$27.13K
Capitalization2.3B
PDSB vs RXRX Comparison Chart
Loading...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PDSB vs. RXRX commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Hold and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (PDSB: $1.26 vs. RXRX: $5.72)
Brand notoriety: PDSB and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 14% vs. RXRX: 50%
Market capitalization -- PDSB: $57.2M vs. RXRX: $2.3B
PDSB [@Biotechnology] is valued at $57.2M. RXRX’s [@Biotechnology] market capitalization is $2.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • PDSB’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • PDSB’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than RXRX.

Price Growth

PDSB (@Biotechnology) experienced а +9.57% price change this week, while RXRX (@Biotechnology) price change was +1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.16%. For the same industry, the average monthly price growth was +1.72%, and the average quarterly price growth was -10.51%.

Reported Earning Dates

PDSB is expected to report earnings on Aug 13, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.3B) has a higher market cap than PDSB($57.2M). RXRX YTD gains are higher at: -15.385 vs. PDSB (-22.699). PDSB has higher annual earnings (EBITDA): -36.65M vs. RXRX (-426.72M). RXRX has more cash in the bank: 594M vs. PDSB (49.8M). PDSB has less debt than RXRX: PDSB (24.7M) vs RXRX (108M). RXRX has higher revenues than PDSB: RXRX (58.5M) vs PDSB (0).
PDSBRXRXPDSB / RXRX
Capitalization57.2M2.3B2%
EBITDA-36.65M-426.72M9%
Gain YTD-22.699-15.385148%
P/E RatioN/AN/A-
Revenue058.5M-
Total Cash49.8M594M8%
Total Debt24.7M108M23%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PDSBRXRX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 23 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA292.036.15
+2.15%
Tesla
SPY554.323.47
+0.63%
SPDR® S&P 500® ETF
AAPL211.211.07
+0.51%
Apple
BTC.X94284.790000-693.960940
-0.73%
Bitcoin cryptocurrency
GME27.26-0.33
-1.20%
GameStop Corp

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with RXRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
+1.61%
RXRX - PDSB
47%
Loosely correlated
-2.05%
KYMR - PDSB
45%
Loosely correlated
+0.24%
ATOS - PDSB
45%
Loosely correlated
+7.09%
CRNX - PDSB
44%
Loosely correlated
+0.60%
ABSI - PDSB
42%
Loosely correlated
-5.02%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-2.05%
CRSP - RXRX
72%
Closely correlated
-1.27%
BEAM - RXRX
62%
Loosely correlated
-0.45%
NTLA - RXRX
60%
Loosely correlated
-3.30%
ABSI - RXRX
59%
Loosely correlated
-5.02%
PRME - RXRX
58%
Loosely correlated
-3.61%
More